Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries. RMD open. 2015;1(1):e000040.

28/02/2022

Finckh A, Neto D, Iannone F, Loza E, Lie E, van Riel P, et al.

Epub 2015/10/29. doi: 10.1136/rmdopen-2014-000040. PubMed PMID: 26509062; PubMed Central PMCID: PMCPMC4613166.